Sponsor Pipeline

Thomas Martin, MD Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT05577000 Anti-BCMA Chimeric Antigen Receptor T Cells for Relapsed or Refractory Multiple Myeloma Refractory Multiple Myeloma Active, Not Recruiting
Disease Areas
Multiple Myeloma (1)
Get alerts when Thomas Martin, MD's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free